January 22, 2018

New Afib Drug Treatments & Rhythm Control Use — StopAfib.org interviews Dr. James Reiffel

StopAfib interviews Dr. James Reiffel Find a transcript and more on Dr. Reiffel at: www.stopafib.org In this video interview at Heart Rhythm 2012, Dr. James Reiffel updates us on new directions in drug treatments for atrial fibrillation. He talks about the combination of ranolazine (Ranexa) and dronedarone (Multaq), both used

Dr. James Reiffel on Atrial Fibrillation Treatments, Including Combining Ranolazine with Dronedarone — Video

At Heart Rhythm 2012, Dr. James Reiffel gave us an update on new medications for treating atrial fibrillation, including the combination of low doses of ranolazine (Ranexa) and dronedarone (Multaq). He also talked about rate control vs. rhythm control for afib, and how the decision can vary by age and level of symptoms. Watch the […]

What Everyone with Atrial Fibrillation Should Know about Multaq (dronedarone)

As a patient, you probably see lots of hype-filled reports about various drugs. After a drug is approved, there’s an inevitable blitz of negative publicity which often scares people away from important new solutions that could help them. There has been so much news lately about Multaq (dronedarone), the drug designed to provide the benefits […]

Dr. Peter Kowey Discusses New Atrial Fibrillation Treatments – Video

In this video interview at Boston Atrial Fibrillation Symposium, Dr. Peter Kowey, President of the Main Line Health Heart Center, talked about a number of exciting new things in the atrial fibrillation world. His topics included the Cabana clinical trials, the Safari catheter ablation registry, dronedarone as a replacement for amiodarone, atrial selective drugs, and […]

StopAfib.org applauds FDA approval of Multaq® (dronedarone), a safer option to amiodarone for atrial fibrillation (afib) patients

We hear from so many afib patients every day about the trials, tribulations, and fears regarding being on amiodarone, or their refusal to take it. Since the FDA approved Multaq® (dronedarone) recently, the most frequent question I’ve fielded has been “When will Multaq® be available?” That happened this week, and the excitement they have shared […]

StopAfib.org Speaks on Behalf of Atrial Fibrillation Patients at FDA Hearing on Amiodarone Replacement

On March 18, 2009, StopAfib.org represented the atrial fibrillation patient community at the FDA Cardiovascular and Renal Drugs Advisory Committee hearings on a replacement for amiodarone. We greatly appreciate you sharing your many stories so that we could share your experiences with the FDA. I had promised to share my comments with the afib patient […]

Warning for Atrial Fibrillation Patients Taking Amiodarone

The U.S. Food and Drug Administration issued a warning to doctors who are prescribing amiodarone for their atrial fibrillation patients saying that those patients should take no more than 20 milligrams of Zocor®, Simcor®, or Vytorin®. Read about FDA warning …